Medicare DMEPOS Competitive Bidding Improvement Act of 2015

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015. H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Client expense: $1,870,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act, all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6/H.R. 34 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions; H.R. 2029 - Omnibus Appropriations Bill, DME provisions; S. 2425 - Patient Access and Medicare Protection Act, all provisions; H.R. 4185/S. 2312 - DME Rural Relief, all provisions; H.R. 3229/S. 2196 - Complex Rehab Accessories Relief, all provisions; S. 2736/H.R. 5210 - Patient Access to Durable Medical Equipment Act of 2016, all provisions.

Client expense: $160,000 · Firm income: Not reported

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform (HR 4771); Medicare physician payment / SGR (HR 2); Medicare Therapeutic Shoes program for persons with diabetes (HR 1221 / S 626 / HR 4756); Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Medicaid program integrity (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425; S 2511); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526, S 2368); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661); budget reform (HR 3660)

Client expense: $140,000 · Firm income: Not reported

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform (HR 4771); Medicare physician payment / SGR (HR 2); Medicare Therapeutic Shoes program for persons with diabetes (HR 1221 / S 626 / HR 4756); Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Medicaid program integrity (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425; S 2511); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526, S 2368); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661); budget reform (HR 3660)

Client expense: $140,000 · Firm income: Not reported

HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule implementation; DMEPOS prior authorization proposed and final rule; S. 2312,DME Access and Stabilization Act of 2015; H.R. 4185, Protecting Access through Competitive�pricing Transition Act of 2015; H.R. 5210 and S. 2736, the Patient Access to Durable Medical Equipment Act of 2016, the Beneficiary Respiratory Equipment Access and Transparency to Home Ventilator Care (BREATH) Act of 2016

Client expense: Not reported · Firm income: $37,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015. H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Client expense: $2,250,000 · Firm income: Not reported

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act, all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions; H.R. 2029 - Omnibus Appropriations Bill, DME provisions; S. 2425 - Patient Access and Medicare Protection Act, all provisions; H.R. 4185/S. 2312 - DME Rural Relief, all provisions; H.R. 3229/S. 2196 - Complex Rehab Accessories Relief, all provisions; S. 2736/H.R. 5210 - Patient Access to Durable Medical Equipment Act of 2016, all provisions.

Client expense: $150,000 · Firm income: Not reported

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.

Client expense: $1,550,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office

HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule implementation; DMEPOS prior authorization proposed and final rule; S. 2312,DME Access and Stabilization Act of 2015; H.R. 4185, Protecting Access through Competitive�pricing Transition Act of 2015; H.R. 5210 and S. 2736, the Patient Access to Durable Medical Equipment Act of 2016

Client expense: Not reported · Firm income: $37,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform (HR 4771); Medicare physician payment / SGR (HR 2); Medicare Therapeutic Shoes program for persons with diabetes (HR 1221 / S 626 / HR 4756); Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Medicaid program integrity (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425; S 2511); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526, S 2368); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661); budget reform (HR 3660)

Client expense: $140,000 · Firm income: Not reported

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act, all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions; H.R. 2029 - Omnibus Appropriations Bill, DME provisions; S. 2425 - Patient Access and Medicare Protection Act, all provisions; H.R. 4185/S. 2312 - DME Rural Relief, all provisions; H.R. 3229/S. 2196 - Complex Rehab Accessories Relief, all provisions; S. 2736/H.R. 5210 - Patient Access to Durable Medical Equipment Act of 2016, all provisions.

Client expense: $140,000 · Firm income: Not reported

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.

Client expense: $2,080,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office

HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule implementation; DMEPOS prior authorization proposed and final rule; S. 2312,DME Access and Stabilization Act of 2015; H.R. 4185, Protecting Access through Competitive�pricing Transition Act of 2015; S. 2736, the Patient Access to Durable Medical Equipment Act of 2016

Client expense: Not reported · Firm income: $37,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.

Client expense: $2,090,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act, all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions. H.R. 2029 - Omnibus Appropriations Bill, DME provisions; S. 2425 - Patient Access and Medicare Protection Act, all provisions; H.R. 4185/S. 2312 - DME Rural Relief, all provisions; H.R. 3229/S. 2196 - Complex Rehab Accessories Relief, all provisions; S. 2736 - Patient Access to Durable Medical Equipment Act of 2016, all provisions.

Client expense: $120,000 · Firm income: Not reported

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform (HR 4771); Medicare physician payment / SGR (HR 2); Medicare Therapeutic Shoes program for persons with diabetes (HR 1221 / S 626); Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Medicaid program integrity (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425; S 2511); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526, S 2368); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661)

Client expense: $140,000 · Firm income: Not reported

Implementation of the Medicare Improvements for Patients and Providers Act of 2008, reimbursement for home oxygen therapy. CMS regulations concerning the DMEPOS Competitive Bidding program, inhalation drugs and sleep disorder therapies. Regulatory issues related to Medicare inhalation drug Therapies and oxygen reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity. Public Law 113-93 - The Protecting Access to Medicare Act of 2014 - Medicare DME reimbursement issues. Participated in discussions with HHS/CMS staff and congressional staff on audit activities and settlement of appeals. Participated in discussions with congressional and HHS/CMS staff about prior authorization and prospective payment reforms affecting DME suppliers. Participated in discussions with HHS/CMS staff concerning Medicare reimbursement for home based International Normalized Ratio (INR) monitoring services. H.R.1470 and S. 810, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - preventing cuts to Medicare home oxygen services. Public Law 114-10, the Medicare Access and CHIP Reauthorization Act - preventing cuts to Medicare home oxygen services. H.R.284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 4185, Protecting Access through Competitive-pricing Transition (PACT) Act, all provisions. S. 2312, the DME Access and Stabilization Act, all provisions. S. 2368, Audit & Appeals Fairness, Integrity, and Reforms in Medicare Act of 2015, all provisions. Public Law 114-113, Consolidated Appropriations Act, 2016, provisions relating to Medicare and Medicaid payment for durable medical equipment. Public Law 114-74, Bipartisan Budget Act of 2015, provisions relating to Medicare and and Medicaid payment for durable medical equipment.

Client expense: Not reported · Firm income: $75,000

HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; GAO and OIG reports related to DMEPOS; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule implementation; DMEPOS prior authorization proposed and final rule; S. 2312,DME Access and Stabilization Act of 2015; H.R. 4185, Protecting Access through Competitive�pricing Transition Act of 2015.

Client expense: Not reported · Firm income: $37,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.

Client expense: $2,060,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office

Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) Medical Device related issues Medicare Audit Improvement Act, Medical Device issues Administrative Relief and Accurate Medicare Payments, Medical device issues H.R.1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, Medical device issues Public Law 114-10, Medicare Access and CHIP Reauthorization Act of 2015, Medical device issues H.R.284/S.148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015, Medical device issues H.R.6, 21st Century Cures Act, Medical device issues H.R.4185, Protecting Access through Competitive-pricing Transition (PACT) Act of 2015, Medical device issues S.2312, DME Access and Stabilization Act of 2015, Medical device issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act, all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions. H.R. 2029 - Omnibus Appropriations Bill, DME provisions; S. 2425 - Patient Access and Medicare Protection Act, all provisions; H.R. 4185/S. 2312 - DME Rural Relief, all provisions; H.R. 3229/S. 2196 - Complex Rehab Accessories Relief, all provisions.

Client expense: $130,000 · Firm income: Not reported

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform; Medicare physician payment / SGR (HR 2; HR 1470; S 810); Medicare Therapeutic Shoes program for persons with diabetes; Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661)

Client expense: $140,000 · Firm income: Not reported

Implementation of the Medicare Improvements for Patients and Providers Act of 2008, reimbursement for home oxygen therapy. CMS regulations concerning the DMEPOS Competitive Bidding program, inhalation drugs and sleep disorder therapies. Regulatory issues related to Medicare inhalation drug Therapies and oxygen reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity. Public Law 113-93 - The Protecting Access to Medicare Act of 2014 - Medicare DME reimbursement issues. Participated in discussions with HHS/CMS staff and congressional staff on audit activities and settlement of appeals. Participated in discussions with congressional and HHS/CMS staff about prior authorization and prospective payment reforms affecting DME suppliers. Participated in discussions with HHS/CMS staff concerning Medicare reimbursement for home based International Normalized Ratio (INR) monitoring services. H.R.1470 and S. 810, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - preventing cuts to Medicare home oxygen services. Public Law 114-10, the Medicare Access and CHIP Reauthorization Act - preventing cuts to Medicare home oxygen services. H.R.284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015.

Client expense: Not reported · Firm income: $75,000

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.

Client expense: $1,740,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office

HR 605/S 275 - The Medicare Home Infusion Site of Care Act - Lobbied in support of passage of the legislation to ensure Medicare beneficiaries have access to home infusion. External infusion pump draft revisions to inotropic coverage criteria, NHIA commented to Medicare DMAC on August 31, 2015 IVIG Coverage Demonstration - Worked with CMS to ensure the IVIG Demonstration is carried out in a manner that is beneficial to Medicare beneficiaries. Medicare Audits and ALJ Hearings - Continued efforts supporting reforms to the Medicare Audits system. Direct Medicare payment to pharmacies for drugs used in implanted infusion pumps - Worked in support of legislation to provide direct payment Competitive bidding of DMEPOS - worked to ensure competitive bidding does not adversely affect the home infusion industry's ability to provide infusion services, Supported binding bid legislation - HR 264 / S 148 HR 6 / HR 2581 / HR 2570 - lobbied House and Senate against ASP infusion drug pricing without inclusion of a services payment for home infusion pharmacies under the Medicare DME Program.

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; GAO and OIG reports related to DMEPOS; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule implementation.

Client expense: Not reported · Firm income: $37,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.

Client expense: $1,720,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.

Client expense: $2,100,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office

Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) Medical Device related issues Medicare Audit Improvement Act, Medical Device issues Administrative Relief and Accurate Medicare Payments, Medical device issues H.R.1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, Medical device issues Public Law 114-10, Medicare Access and CHIP Reauthorization Act of 2015, Medical device issues H.R.284/S.148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015, Medical device issues H.R.6, 21st Century Cures Act, Medical device issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act; all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions.

Client expense: $110,000 · Firm income: Not reported

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform; Medicare physician payment / SGR (HR 2; HR 1470; S 810); Medicare Therapeutic Shoes program for persons with diabetes; Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661)

Client expense: $140,000 · Firm income: Not reported

Implementation of the Medicare Improvements for Patients and Providers Act of 2008, reimbursement for home oxygen therapy. CMS regulations concerning the DMEPOS Competitive Bidding program, inhalation drugs and sleep disorder therapies. Regulatory issues related to Medicare inhalation drug Therapies and oxygen reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity. Public Law 113-93 - The Protecting Access to Medicare Act of 2014 - Medicare DME reimbursement issues. Participated in discussions with HHS/CMS staff and congressional staff on audit activities and settlement of appeals. Participated in discussions with congressional and HHS/CMS staff about prior authorization and prospective payment reforms affecting DME suppliers. Participated in discussions with HHS/CMS staff concerning Medicare reimbursement for home based International Normalized Ratio (INR) monitoring services. H.R.1470 and S. 810, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - preventing cuts to Medicare home oxygen services. Public Law 114-10, the Medicare Access and CHIP Reauthorization Act - preventing cuts to Medicare home oxygen services. H.R.284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015.

Client expense: Not reported · Firm income: $75,000

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.

Client expense: $2,110,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office

HR 605/S 275 - The Medicare Home Infusion Site of Care Act - Lobbied in support of passage of the legislation to ensure Medicare beneficiaries have access to home infusion. IVIG Coverage Demonstration - Worked with CMS to ensure the IVIG Demonstration is carried out in a manner that is beneficial to Medicare beneficiaries. Medicare Audits and ALJ Hearings - Continued efforts supporting reforms to the Medicare Audits system. Direct Medicare payment to pharmacies for drugs used in implanted infusion pumps - Worked in support of legislation to provide direct payment Competitive bidding of DMEPOS - worked to ensure competitive bidding does not adversely affect the home infusion industry's ability to provide infusion services, Supported binding bid legislation - HR 264 / S 148 HR 6 / HR 2581 / HR 2570 - lobbied against ASP infusion drug pricing without inclusion of a services payment for home infusion pharmacies under the Medicare DME Program.

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 605/S 275 - The Medicare Home Infusion Site of Care Act - Lobbied in support of passage of the legislation to ensure Medicare beneficiaries have access to home infusion. IVIG Coverage Demonstration - Worked with CMS to ensure the IVIG Demonstration is carried out in a manner that is beneficial to Medicare beneficiaries. Medicare Audits and ALJ Hearings - Continued efforts supporting reforms to the Medicare Audits system. Direct Medicare payment to pharmacies for drugs used in implanted infusion pumps - Worked in support of legislation to provide direct payment Competitive bidding of DMEPOS - worked to ensure competitive bidding does not adversely affect the home infusion industry's ability to provide infusion services, Supported binding bid legislation - HR 264 / S 148

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; GAO and OIG reports related to DMEPOS; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule.

Client expense: Not reported · Firm income: $37,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) Medical Device related issues Medicare Audit Improvement Act, Medical Device issues Administrative Relief and Accurate Medicare Payments, Medical device issues H.R.1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, Medical device issues Public Law 114-10, Medicare Access and CHIP Reauthorization Act of 2015, Medical device issues H.R.284/S.148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015, Medical device issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act; all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015, competitive bidding provisions.

Client expense: $110,000 · Firm income: Not reported

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform; Medicare physician payment / SGR (HR 2; HR 1470; S 810); Medicare Therapeutic Shoes program for persons with diabetes; Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Veterans Admin. provider recruitment, retention and reimbursement; Medicaid access to podiatry (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661); student loan assistance (HR 1707)

Client expense: $140,000 · Firm income: Not reported

H.R. 1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015; H.R. 6, 21st Century Cures Act

Client expense: $138,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of the Medicare Improvements for Patients and Providers Act of 2008, reimbursement for home oxygen therapy. CMS regulations concerning the DMEPOS Competitive Bidding program, inhalation drugs and sleep disorder therapies. Regulatory issues related to Medicare inhalation drug Therapies and oxygen reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity. Public Law 113-93 - The Protecting Access to Medicare Act of 2014 - Medicare DME reimbursement issues. Participated in discussions with HHS/CMS staff and congressional staff on audit activities and settlement of appeals. Participated in discussions with congressional and HHS/CMS staff about prior authorization and prospective payment reforms affecting DME suppliers. Participated in discussions with HHS/CMS staff concerning Medicare reimbursement for home based International Normalized Ratio (INR) monitoring services. H.R.1470 and S. 810, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - preventing cuts to Medicare home oxygen services. Public Law 114-10, the Medicare Access and CHIP Reauthorization Act - preventing cuts to Medicare home oxygen services. H.R.284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015.

Client expense: Not reported · Firm income: $75,000

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.

Client expense: $1,750,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office

HR 2 Medicare Access and CHIP Reauthorization Act of 2015; HR 284 Medicare DMEPOS Competitive Bidding Improvement Act of 2015; S 148 Medicare DMEPOS Competitive Bidding Improvement Act of 2015; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; GAO and OIG reports related to DMEPOS; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule.

Client expense: Not reported · Firm income: $37,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR 605/S 275 - The Medicare Home Infusion Site of Care Act - Lobbied in support of passage of the legislation to ensure Medicare beneficiaries have access to home infusion. IVIG Coverage Demonstration - Worked with CMS to ensure the IVIG Demonstration is carried out in a manner that is beneficial to Medicare beneficiaries. Medicare Audits and ALJ Hearings - Continued efforts supporting reforms to the Medicare Audits system. Direct Medicare payment to pharmacies for drugs used in implanted infusion pumps - Worked in support of legislation to provide direct payment Competitive bidding of DMEPOS - worked to ensure competitive bidding does not adversely affect the home infusion industry's ability to provide infusion services, Supported binding bid legislation - HR 264 / S 148

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015

Client expense: $201,631 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 838 (Construction Coalition Procurement Reform Legislation), SBA Bond Guarantee Program, individual sureties, Miller Act bonding thresholds, bonding for public private partnerships, S148 (bid bond for medical equipment suppliers), Customs bonds, technical assistance and bonding programs for small and minority contractors,

Client expense: $30,000 · Firm income: Not reported

Government targets: Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), U.S. Customs & Border Protection